A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
A novel optical biosensor for the early diagnosis of sepsis and severe COVID-19: the PROUD study
[post]
2020
unpublished
Background The accuracy of a new optical biosensor (OB) point-of-care device for the detection of severe infections is studied.Methods The OB emits different wavelengths and outputs information associated with heart rate, pulse oximetry, levels of nitric oxide and kidney function. At the derivation phase, recordings were done every two hours for three consecutive days after hospital admission in 142 patients at high-risk for sepsis by placing the OB on the forefinger. At the validation phase,
doi:10.21203/rs.3.rs-38165/v1
fatcat:jjem5uce25ecnaljj7bxndbgcu